Premier Research Fortifies Cell and Gene Therapy Leadership Team, Strengthening End-to-End Capabilities in Complex Asset Development.
In: Gene Therapy Weekly, 2023-05-05, S. 1058-1058
serialPeriodical
Zugriff:
Bioengineering, Biotechnology, Drugs and Therapies, Gene Therapy, Genetics, Premier Research, Therapy Keywords: Bioengineering; Biotechnology; Drugs and Therapies; Gene Therapy; Genetics; Premier Research; Therapy EN Bioengineering Biotechnology Drugs and Therapies Gene Therapy Genetics Premier Research Therapy 1058 1058 1 05/02/23 20230505 NES 230505 2023 MAY 5 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Premier Research announced the addition of Kenneth Ndugga-Kabuye, M.D., FACMG, as VP, Cell & Gene Therapy to the strategic Cell & Gene Therapy (CGT) Leadership Team. [Extracted from the article]
Copyright of Gene Therapy Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Premier Research Fortifies Cell and Gene Therapy Leadership Team, Strengthening End-to-End Capabilities in Complex Asset Development.
|
---|---|
Zeitschrift: | Gene Therapy Weekly, 2023-05-05, S. 1058-1058 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1078-2842 (print) |
Schlagwort: |
|
Sonstiges: |
|